Status:

COMPLETED

Telomere Associated Variables (TAVs) in Prostate Cancer

Lead Sponsor:

Life Length SL

Conditions:

Prostate Cancer

Eligibility:

MALE

18+ years

Brief Summary

This research project results from the interest in continuing the collaboration with the previous LL-HURS-ONC001 clinical validation study, which gives cause to the present study. LL-HURS-ONC001 was c...

Detailed Description

In this study, patient inclusion and sample collection are multicentric. Sample analysis will be carried out at Life Length's laboratories at the Madrid Science Park in Canto Blanco university campus....

Eligibility Criteria

Inclusion

  • To be over 18 years of age.
  • To have given written consent to participate in the study.
  • To be classified as a patient at prostate cancer risk according to criteria of high PSA levels (\<10 ng/ml) and the urologist's decision to perform a prostate biopsy in standard of care.
  • To be diagnosed by a prostate biopsy with or without concomitant MRI.
  • Caucasic race

Exclusion

  • Patients that have received Alpha-5 reductase therapy.
  • Existing serious active liver, lung or kidney disease, as well as severe active infections.
  • Existing serious disease or psychiatric disorder that prevents them from expressing informed consent and/or if patients are not able to follow protocol procedures and give their informed consent.
  • Patients at risk resulting from conventional blood extraction.
  • Subjects with active neoplasm diagnosed during the past five years.

Key Trial Info

Start Date :

July 15 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 21 2023

Estimated Enrollment :

509 Patients enrolled

Trial Details

Trial ID

NCT04124900

Start Date

July 15 2019

End Date

September 21 2023

Last Update

October 5 2023

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Urological Research Network, Corp.

Hialeah, Florida, United States, 33016

2

Houston Methodist Research Institute

Houston, Texas, United States, 77030

3

Hospital Infanta Margarita

Cabra, Córdoba, Spain, 14940

4

Instituto Médico Tecnológico

Barcelona, Spain, 08024

Telomere Associated Variables (TAVs) in Prostate Cancer | DecenTrialz